Trial intelligence / Profile preview

Phase III Trial of Duloxetine in Fibromyalgia

jRCT2080221737Phase 3

Sponsor
Shionogi & Co., Ltd.
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of duloxetine in fibromyalgia (FM), sponsored by Shionogi & Co., Ltd.

02

Drugs

duloxetine
03

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on jRCT2080221737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call